Clinical Trial Update: Effects of Rifaximin in Patients With Acute Alcoholic Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating rifaximin in patients with acute alcoholic hepatitis is reported, with the trial status listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Hospital Universitari Vall d'Hebron Research Institute | Conditions: Alcoholic Hepatitis | Phase 2 | Status: UNKNOWN